S-Phase Checkpoints Regulate Apo2 Ligand/Trail and CPT-11-induced Apoptosis of Prostate Cancer Cells

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-05-0414
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Multiple Mechanisms Underlie Resistance of Leukemia Cells to Apo2 Ligand/Trail

Molecular Cancer Therapeutics
Cancer ResearchOncology
2006English

221. TRAIL-R2 and HRK Mediate Angiotensin Type 2 Receptor-Induced Apoptosis of Human Prostate Cancer Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Butyrate-Induced Apoptosis in Prostate Cancer Cells

1999English

SKP2 Confers Resistance of Pancreatic Cancer Cells Towards TRAIL-induced Apoptosis

International Journal of Oncology
Cancer ResearchOncology
2010English

TRAIL-induced Apoptosis of Thyroid Cancer Cells: Potential for Therapeutic Intervention

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

The Role of NF- B in TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis of Melanoma Cells

Journal of Immunology
AllergyImmunology
2001English

Resistance of Prostate Cancer Cells to Soluble TNF-related Apoptosis-Inducing Ligand (TRAIL/Apo2L) Can Be Overcome by Doxorubicin or Adenoviral Delivery of Full-Length TRAIL

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2002English

Ouabain Downregulates McL-1 and Sensitizes Lung Cancer Cells to TRAIL-induced Apoptosis

American Journal of Physiology - Cell Physiology
PhysiologyCell Biology
2013English

TRAIL Is a Key Target in S-Phase Slowing-Dependent Apoptosis Induced by Interferon-Β in Cervical Carcinoma Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy